Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Camerlo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Transfusion|March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb levelV Ivanov, C Faucher, M Mohty, et al.
Pancreas|September 26, 2003
Docetaxel and radiotherapy and pancreatic cancerF Viret, M Ychou, A Gonçalves, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Breast Cancer Research and Treatment|August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapyP Viens, J Jacquemier, V J Bardou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Bulletin Du Cancer|January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]P Viens, F Bertucci, G Gravis, et al.
Leukemia|April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantationC Chabannon, A-G Le Corroller, F Viret, et al.
International Journal of Oncology|July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamideC Chabannon, J L Blache, I Sielleur, et al.
Journal of Hematotherapy|December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recoveryC Faucher, A G Le Corroller, C Chabannon, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Transfusion|March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb levelV Ivanov, C Faucher, M Mohty, et al.
Pancreas|September 26, 2003
Docetaxel and radiotherapy and pancreatic cancerF Viret, M Ychou, A Gonçalves, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Breast Cancer Research and Treatment|August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapyP Viens, J Jacquemier, V J Bardou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Bulletin Du Cancer|January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]P Viens, F Bertucci, G Gravis, et al.
Leukemia|April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantationC Chabannon, A-G Le Corroller, F Viret, et al.
International Journal of Oncology|July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamideC Chabannon, J L Blache, I Sielleur, et al.
Journal of Hematotherapy|December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recoveryC Faucher, A G Le Corroller, C Chabannon, et al.
Pageof 5